Abstract
There are at least six pharmacologically effective components of cannabis. Their effects on mice include a lowering of body temperature, catalepsy, analgesia and an extension of barbiturate sleeping time, with doses from 25 to 200 mg/kg.
Similar content being viewed by others
References
Mechoulam, R., and Gaoni, Y., Progress in the Chemistry of Organic Natural Products, 25, 175 (Springer, New York, 1967).
Korte, F., and Sieper, H., Annalen, 630, 71 (1960).
Miras, C. J., in Hashish, Ciba Foundation Study Group No. 21 (Churchill, London, 1965).
Garattini, S., in Hashish, Ciba Foundation Study Group No. 21 (Churchill, London, 1965).
Holtzman, D., Lovell, R. A., Jaffe, J. H., and Freedman, D. X., Science, 163, 1464 (1969).
Herrington, L. P., Amer. J. Physiol., 129, 123 (1940).
Loewe, S., J. Pharmac. Exp. Ther., 88, 154 (1946).
Siegmund, E., Cadmus, R., and Lu, G., Proc. Soc. Exp. Biol. Med., 95, 729 (1957).
Cortez, L., Chaud Sob, J., and Louzada, N. L., Third Internat. Pharmacol. Congr., Abstracts, 667 (1966).
Bicher, H. I., and Mechoulam, R., Arch. Int. Pharmacodyn., 172, 24 (1968).
Buxbaum, D., Sanders-Bush, E., and Efron, D. H., Fed. Proc., 28, 735 (1969).
Loewe, S., Arch. Exp. Path. Pharmak., 211, 175 (1950).
Persaud, T. V. N., and Ellingham, A. C., Lancet, ii, 406 (1968).
Geber, W. F., and Schramm, L. C., Arch. Int. Pharmacodyn., 177, 224 (1969).
Persaud, T. V. N., and Ellington, A. C., Lancet, 2, 1306 (1967).
Paton, W. D. M., Brit. J. Pharmacol., 12, 119 (1957).
Paton, W. D. M., and Vizi, E. S., Brit. J. Pharmacol., 35, 10 (1969).
Speden, R. N., Brit. J. Pharmacol., 25, 104 (1965).
Hindmarsh, I., Brit. J. Addiction, 64, 395 (1970).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
GILL, E., PATON, W. & PERTWEE, R. Preliminary Experiments on the Chemistry and Pharmacology of Cannabis. Nature 228, 134–136 (1970). https://doi.org/10.1038/228134a0
Received:
Issue Date:
DOI: https://doi.org/10.1038/228134a0
- Springer Nature Limited
This article is cited by
-
Biological activity of Cannabis compounds: a modern approach to the therapy of multiple diseases
Phytochemistry Reviews (2022)
-
Δ9-Tetrahydrocannabivarin (THCV): a commentary on potential therapeutic benefit for the management of obesity and diabetes
Journal of Cannabis Research (2020)
-
Potential of Cannabinoid Receptor Ligands as Treatment for Substance Use Disorders
CNS Drugs (2019)
-
Novel derivatives of 1,2,3-triazole, cannabinoid-1 receptor ligands modulate gastrointestinal motility in mice
Naunyn-Schmiedeberg's Archives of Pharmacology (2018)
-
Anticipatory nausea in animal models: a review of potential novel therapeutic treatments
Experimental Brain Research (2014)